Company news
Canggang Railway Limited news in 2026
Canggang Railway Limited's news releases, calls and decks from 2026, newest first.
Further delay in despatch of circular in relation to (1) connected transaction in relation to subscription of shares under specific mandate and (2) application for whitewash waiver
November 6, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
November 3, 2026
Delay in despatch of circular in relation to (1) connected transaction in relation to subscription of shares under Specific mandate and (2) application for Whitewash Waiver
October 16, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 5, 2026
(1) Connected transaction in Relation to subscription of shares under Specific mandate and (2) application for Whitewash Waiver
September 29, 2026
Interim Report 2026
September 28, 2026
Nuance Pharma Announces Acceptance for Review of the New Drug Application for Ohtuvayre® (ensifentrine) by the National Medical Products Administration of China for the maintenance treatment of chronic obstructive pulmonary disease
January 26, 2026